New compounds inhibit influenza by altering the virus surface environment

Dual-acting compounds use zanamivir to deliver an acidifying domain to the virus surface.

Researchers developed dual-acting compounds that inhibit influenza. These compounds deliver an acidifying domain via zanamivir to the virus surface.

Most antiviral development tries to produce lock and key inhibitors. This new approach uses compounds to alter the microenvironment of the virion surface.

The compounds create a proton-rich mantle above the virion surface. This makes the surface incompatible with virus entry.

The proton-rich mantle affects the ability of viral hemagglutinin to interact with cellular receptors. This prevents the virus from gaining entry to the cell.

The compounds show exceptional antiviral activity in vitro and in vivo. A single dose protects ferrets and mice against influenza illness.

These compounds work when used either therapeutically or prophylactically.

Key facts

  • Compounds create a proton-rich mantle to stop virus entry.
  • The strategy affects how viral hemagglutinin interacts with cellular receptors.
  • A single dose protects mice and ferrets from influenza illness.

All sections

Edition